Aberrant regulation of mitotic exit in cancer due to RB1 defects

Stable Identifier
R-HSA-9687136
Type
Pathway
Species
Homo sapiens
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Aberrant regulation of mitotic exit in cancer due to RB1 defects
Click the image above or here to open this pathway in the Pathway Browser
RB1 regulates mitotic exit by acting on SKP2, a component of the SCF E3 ubiquitin ligase complex. RB1 facilitates degradation of SKP2 by the anaphase promoting complex/cyclosome (APC/C), thus preventing SKP2-mediated degradation of the cyclin-dependent kinase inhibitor CDKN1B (p27Kip1). RB1-dependent accumulation of p27Kip1 plays an important role in mitotic exit and RB1-mediated tumor suppression (reviewed by Dyson 2016).
Literature References
PubMed ID Title Journal Year
27401552 RB1: a prototype tumor suppressor and an enigma

Dyson, NJ

Genes Dev. 2016
Participants
Events
Participates
as an event of
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cross References
BioModels Database
Authored
Orlic-Milacic, M  (2020-05-07)
Reviewed
Dick, FA  (2020-05-17)
Created
Orlic-Milacic, M  (2020-05-06)
Cite Us!